Toll-like receptors in atopic dermatitis: pathogenesis and therapeutic implications

Toll-like receptors (TLR), the key players of the innate immune system, contribute to the pathogenesis of atopic dermatitis (AD) through multiple pathways. TLRs play a crucial role in delaying barrier repair, promoting Th2-mediated dermatitis, shifting the response toward Th1 in the chronic phase, a...

Full description

Saved in:
Bibliographic Details
Main Authors: Ahmad Vafaeian, Fateme Rajabi, Nima Rezaei
Format: Article
Language:English
Published: Elsevier 2025-02-01
Series:Heliyon
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2405844025006061
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1823864427477204992
author Ahmad Vafaeian
Fateme Rajabi
Nima Rezaei
author_facet Ahmad Vafaeian
Fateme Rajabi
Nima Rezaei
author_sort Ahmad Vafaeian
collection DOAJ
description Toll-like receptors (TLR), the key players of the innate immune system, contribute to the pathogenesis of atopic dermatitis (AD) through multiple pathways. TLRs play a crucial role in delaying barrier repair, promoting Th2-mediated dermatitis, shifting the response toward Th1 in the chronic phase, and contributing to the establishment of the itch-scratch cycle, as well as mediating the effects of UV radiation. The dysregulation of proinflammatory and immunomodulatory effects of TLRs can be attributed to their ligand structures, receptor heterodimerization, the relative frequency of each TLR, interactions with other receptors/signalling pathways, cytokine milieu, and genetic polymorphisms. Current AD treatments like vitamin-D analogs, tacrolimus, and cyclosporine partially work through TLR modulation. Direct TLR stimulation using different compounds has shown therapeutic benefits in preclinical studies. However, significant challenges exist, including off-target effects due to ubiquitous TLR expression and complex roles in immune responses. Future directions include CRISPR-based gene editing to understand TLR functions, development of specific TLR modulators for targeted therapy, and machine learning applications to predict drug responses and identify novel ligands. Patient heterogeneity, including the presence or absence of polymorphisms, variations in TLR expression levels, and differences in immune responses, underscores the need for personalized therapeutic approaches.
format Article
id doaj-art-b4427e81b78d4c0d894314ae4491d43e
institution Kabale University
issn 2405-8440
language English
publishDate 2025-02-01
publisher Elsevier
record_format Article
series Heliyon
spelling doaj-art-b4427e81b78d4c0d894314ae4491d43e2025-02-09T05:00:39ZengElsevierHeliyon2405-84402025-02-01113e42226Toll-like receptors in atopic dermatitis: pathogenesis and therapeutic implicationsAhmad Vafaeian0Fateme Rajabi1Nima Rezaei2Universal Scientific Education and Research Network (USERN), Tehran, Iran; Autoimmune Bullous Diseases Research Center, Tehran University of Medical Sciences, Tehran, IranUniversal Scientific Education and Research Network (USERN), Tehran, Iran; Center for Research & Training in Skin Diseases & Leprosy, Tehran University of Medical Sciences, Tehran, IranUniversal Scientific Education and Research Network (USERN), Tehran, Iran; Network of Immunity in Infection, Malignancy and Autoimmunity (NIIMA), Universal Scientific Education and Research Network (USERN), Sheffield, UK; Research Center for Immunodeficiencies, Children's Medical Center, Tehran University of Medical Sciences, Tehran, Iran; Department of Immunology, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran; Corresponding author. Universal Scientific Education and Research Network (USERN), Tehran, Iran.Toll-like receptors (TLR), the key players of the innate immune system, contribute to the pathogenesis of atopic dermatitis (AD) through multiple pathways. TLRs play a crucial role in delaying barrier repair, promoting Th2-mediated dermatitis, shifting the response toward Th1 in the chronic phase, and contributing to the establishment of the itch-scratch cycle, as well as mediating the effects of UV radiation. The dysregulation of proinflammatory and immunomodulatory effects of TLRs can be attributed to their ligand structures, receptor heterodimerization, the relative frequency of each TLR, interactions with other receptors/signalling pathways, cytokine milieu, and genetic polymorphisms. Current AD treatments like vitamin-D analogs, tacrolimus, and cyclosporine partially work through TLR modulation. Direct TLR stimulation using different compounds has shown therapeutic benefits in preclinical studies. However, significant challenges exist, including off-target effects due to ubiquitous TLR expression and complex roles in immune responses. Future directions include CRISPR-based gene editing to understand TLR functions, development of specific TLR modulators for targeted therapy, and machine learning applications to predict drug responses and identify novel ligands. Patient heterogeneity, including the presence or absence of polymorphisms, variations in TLR expression levels, and differences in immune responses, underscores the need for personalized therapeutic approaches.http://www.sciencedirect.com/science/article/pii/S2405844025006061Atopic dermatitisItchPathogenesisToll-like receptorsInnate immunity
spellingShingle Ahmad Vafaeian
Fateme Rajabi
Nima Rezaei
Toll-like receptors in atopic dermatitis: pathogenesis and therapeutic implications
Heliyon
Atopic dermatitis
Itch
Pathogenesis
Toll-like receptors
Innate immunity
title Toll-like receptors in atopic dermatitis: pathogenesis and therapeutic implications
title_full Toll-like receptors in atopic dermatitis: pathogenesis and therapeutic implications
title_fullStr Toll-like receptors in atopic dermatitis: pathogenesis and therapeutic implications
title_full_unstemmed Toll-like receptors in atopic dermatitis: pathogenesis and therapeutic implications
title_short Toll-like receptors in atopic dermatitis: pathogenesis and therapeutic implications
title_sort toll like receptors in atopic dermatitis pathogenesis and therapeutic implications
topic Atopic dermatitis
Itch
Pathogenesis
Toll-like receptors
Innate immunity
url http://www.sciencedirect.com/science/article/pii/S2405844025006061
work_keys_str_mv AT ahmadvafaeian tolllikereceptorsinatopicdermatitispathogenesisandtherapeuticimplications
AT fatemerajabi tolllikereceptorsinatopicdermatitispathogenesisandtherapeuticimplications
AT nimarezaei tolllikereceptorsinatopicdermatitispathogenesisandtherapeuticimplications